Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
Clinical trial NCT06829329 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06829329
- Sponsor
- Ausper Biopharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-13
- Primary completion
- 2026-08-02
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.